CSPC Pharmaceutical Group Ltd/ HK1093012172 /
2024-06-19 10:08:02 AM | Chg. +0.13 | Volume | Bid10:08:03 AM | Ask10:08:03 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
6.73HKD | +1.97% | 32.37 mill. Turnover: 192 mill. |
6.72Bid Size: 54,000 | 6.73Ask Size: 102,000 | 80.15 bill.HKD | - | - |
GlobeNewswire
04-02
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Necti...
GlobeNewswire
01-26
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encourag...
GlobeNewswire
2018-12-17
Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...
GlobeNewswire
2018-01-13
North America will remain the Most Attractive Market for Vitamins and Derivative Over 2026
GlobeNewswire
2017-10-09
DSM Sinochem Pharmaceuticals Initiates Patent Litigation Against CSPC Pharmaceutical Group Ltd., Inn...
GlobeNewswire
2017-10-09
DSM Sinochem Pharmaceuticals Initiates Patent Litigation Against CSPC Pharmaceutical Group Ltd., Inn...